6-months off GLP-1 update : r/GLPGrad
US$ 25.29
glp 1 approval Market Overview: GLP-1 Agonists and the Obesity Market | Blog Indications for GLP-1/GIP RA Summary
Description
Novo Nordisk successfully completes the first phase 3a trial, PIONEER 1, with oral semaglutide
But weight loss is not fat loss
May 4, 2025: New study suggests more adverse events associated with compounded GLP-1s than standard formulations Major Stories New research shows a correlation between compounded weight loss and diabetes injectables and increased adverse events
This is medicine, not mail-order prescriptions
To date, however, no studies performed in humans are available
